Relation between hepatic and renal function tests and ultrastructural changes indced by 2-N-methylpiperazinomethyl-1,3-diazafluoranthen 1-oxide (AC-3579), a new experimental antileukemic drug.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001372:Aza Compounds / Q000494:pharmacology; D001835:Body Weight / Q000187:drug effects; D005449:Fluorenes / Q000494:pharmacology*; D007668:Kidney / Q000187:drug effects / Q000648:ultrastructure*; D008099:Liver / Q000187:drug effects / Q000648:ultrastructure*; D008111:Liver Function Tests; D008297:Male; D010879:Piperazines / Q000494:pharmacology*; D051381:Rats; D013997:Time Factors
D000970:Antineoplastic Agents; D001372:Aza Compounds; D005449:Fluorenes; D010879:Piperazines